[1] ANDES D, VAN OGTROP ML, PENG J, et al.In vivo pharmacodynamics of a new oxazolidinone (linezolid)[J]. Antimicrob Agents Chemother, 2002, 46(11): 3484-3489. [2] ZHU S, CHEN Z, JIANG Q, et al.Distribution and drug resistance of main pathogens in 1,538 cases of neonatal pneumonia[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2020, 26(11): 44-47. [3] BAGGA B, BUCKINGHAM S, ARNOLD S, et al.Increasing linezolid-resistant enterococcus in a children's hospital[J]. Pediatr Infect Dis J, 2018, 37(3): 242-244. [4] TANG L, FANG J, WANG SN, et al.Clinical efficacy and safety of Vancomycin compared with Linezolid for the treatment of neonatal gram-positive bacterial sepsis[J]. Chin J Pediatr(中华儿科杂志), 2016, 54(9): 686-691. [5] LIN SM, LUO X, YANG XY, et al.Comparison of efficacy and safety of Linezolid and Vancomycin in the treatment of neonatal gram-positive coccal pneumonia[J]. Evaluation and Analysis of Drug-use in Hospitals of China(中国医院用药评价与分析), 2020, 20(1): 53-59. [6] LIANG YW, ZOU J.Drug utilization evaluation of voriconazole injection based on weighted TOPSIS methods[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(3): 186-189. [7] Ministry of Health of the People's Republic of China. Measures for the administration of clinical application of antibacterial drugs[J].Chinese Journal of Clinical Infectious Diseases(中华临床感染病杂志), 2012, (4): 193-196. [8] General Office of the National Health and Family Planning Commission, Office of the National Administration of Traditional Chinese Medicine, General Logistics Department, Ministry of Health Drug Equipment Bureau. Notice on the issuance of guidelines for clinical use of antimicrobial drugs (2015 edition)[J].Bulletin of the National Health and Family Planning Commission of the People's Republic of China(中华人民共和国国家卫生和计划生育委员会公报), 2015, 13(7): 29. [9] Chin J Exp Clin Infect Dis. Prevention and control of methicillin-resistant Staphylococcus aureus infection expert consensus(2011 new edition)[J]. Chin J Exp Clin Infect Dis (Electronic Edition)(中华实验和临床感染病杂志(电子版)), 2011, 5(3): 372-384. [10] National Health Commission of the People's Republic of China, State Administration of Traditional Chinese Medicine. Guidelines for the diagnosis and treatment of community-acquired pneumonia in children(2019 edition)[J]. Chinese Journal of Clinical Infectious Diseases(中华临床感染病杂志), 2019(1): 6-13. [11] GUO HX, SHU LZ.Analysis of risk factors influencing multiple drug resistant organism infection in cardiothoracic surgery patients[J].Hospital Management Forum(医院管理论坛), 2021, 38(2): 66-68. [12] LI SC, YE Q, XU H, et al.Population pharmacokinetics and dosing optimization of linezolid in pediatric patients[J]. Antimicrob Agents Chemother, 2019, 63(4): e02387-18. [13] WANG YJ, WANG XL, QIAN SY, et al. A retrospective analysis of Linezolid-associated Thombocytopenia in children with severe infection[J/OL]. Chinese Journal of Pharmacovigilance(中国药物警戒). (2021-02-02) [2021-06-25 ].https://hypt02.cnki.net/KCMS/detail/detail.aspx?dbcode=PHAJ&dbname=PHATLKCAPJLAST&filename=YWJJ2021020100T&. [14] LI SS, LONG YH.TOPSIS method based large medical equipment performance evaluation in a grade-A tertiary public hospital of Guangzhou[J]. Medicine and Society(医学与社会), 2021, 34(3): 40-44. [15] SONG L, TIAN WJ, JI HH.Drug use evaluation of vancomycin used in neonates based on weighted TOPSIS method[J]. Chin J New Drugs Clin Rem(中国新药与临床),2016, 35(5): 369-373. [16] WANG GF, LIU RF, LI XQ, et al.Evaluation of drug use of tigecycline based on TOPSIS method[J]. Chin Hosp Pharm J(中国医院药学), 2019, 39(4): 381-389. [17] SONG JW, LIU L, XU SS, et al.Evaluation of reasonableness Aidi injection based on weighted TOPSIS method[J]. Central South Pharmacy(中南药学), 2019, 39(4): 381-389. |